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The powerful regulation of bone mass exerted by the
brain suggests the existence of bone-derived signals
modulating this regulation or other functions of the
brain. We show here that the osteoblast-derived hor-
mone osteocalcin crosses the blood-brain barrier,
binds to neurons of the brainstem,midbrain, and hip-
pocampus, enhances the synthesis of monoamine
neurotransmitters, inhibits GABA synthesis, pre-
vents anxiety and depression, and favors learning
and memory independently of its metabolic func-
tions. In addition to these postnatal functions,
maternal osteocalcin crosses the placenta during
pregnancy and prevents neuronal apoptosis before
embryos synthesize this hormone. As a result, the
severity of the neuroanatomical defects and learning
and memory deficits of Osteocalcin/mice is deter-
mined by the maternal genotype, and delivering
osteocalcin to pregnant Osteocalcin/mothers res-
cues these abnormalities in their Osteocalcin/
progeny. This study reveals that the skeleton via
osteocalcin influences cognition and contributes to
the maternal influence on fetal brain development.
INTRODUCTION
Bone was recently identified as an endocrine organ (Guntur and
Rosen, 2012). A hormone secreted by osteoblasts, osteocalcin,
affects physiological processes as diverse as energy expendi-
ture, glucose homeostasis, and male fertility (Ferron et al.,
2010; Lee et al., 2007; Oury et al., 2011). The latter function of228 Cell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc.osteocalcin led to the identification of its only known receptor,
Gprc6a, which is expressed on Leydig cells (Oury et al., 2010;
Pi and Quarles, 2012). Given that most hormones act in many
organs and regulate multiple physiological processes, it is likely
that the spectrum of endocrine functions of osteocalcin is
broader than what is already known.
In another development of skeletal biology, the brain was
shown to determine bone mass accrual (Karsenty and Ferron,
2012). This was revealed while studying the mechanisms
whereby leptin inhibits bone mass accrual in mice, rats, sheep,
and humans (Ducy et al., 2000; Elefteriou et al., 2004; Pogoda
et al., 2006; Vaira et al., 2012). A systematic, step-wise, and
cell-specific genetic dissection in the mouse demonstrated
that leptin does so by signaling in brainstem neurons to prevent
the synthesis of serotonin, a neurotransmitter that decreases the
activity of the sympathetic nervous system, which in turn inhibits
bone mass accrual (Oury et al., 2010; Takeda et al., 2002; Yadav
et al., 2009). The importance of this serotonin-dependent regula-
tion of bone mass accrual is evidenced by the fact that serotonin
reuptake inhibitors that increase intrasynaptic concentrations of
serotonin in the brain can affect bone mass in humans (Gardier
et al., 1996).
Because it is so powerful (the absence of leptin signaling over-
rides the deleterious effect of the lack of sex steroid hormones on
bone mass), this mode of regulation of bone mass raises the
following questions: does bone signal back to the brain? If it
does, what are the identities and functions of these bone-derived
signals? These questions are also prompted by a clinical obser-
vation. Patients affected with Cleidocranial dysplasia (CCD), a
disease caused by mutations in the osteoblast-specific tran-
scription factor Runx2, often demonstrate cognitive impairment
(McBrien et al., 2006; Nagamatsu et al., 2012; Soule, 1946).
Runx2 is the main regulator of Osteocalcin (Ocn) expression
(Ducy et al., 1997).
Clinical outcome studies and experimental evidence gathered
in animal models both indicate that maternal health during preg-
nancy is a determinant of embryonic development (Challis, 2012;
Hales and Barker, 1992; Lawlor et al., 2012). Any direct maternal
influence on vertebrate embryonic development should occur
through the placenta, an organ allowing the transfer of circulating
molecules from the mother to the embryo. However, maternally
derivedmolecules that cross the placenta and affect brain devel-
opment and functions in the progeny have not yet been identi-
fied. Because maternal health is a risk factor for neurologic
and psychiatric diseases in the offspring, this is an important
question to study (Van den Bergh et al., 2005; Weinstock, 2008).
This studywas initiated to determinewhether the skeleton reg-
ulates any function of the brain. Testing this hypothesis revealed
that osteocalcin crosses the blood-brain barrier (BBB), binds to
neurons in the brainstem,midbrain, and hippocampus, and influ-
ences the synthesis of several neurotransmitters. Consequently,
osteocalcin favors postnatally, and independently of its meta-
bolic role, several behaviors by signaling in the brain. As impor-
tantly, during pregnancy maternal osteocalcin crosses the
placenta and prevents neuronal apoptosis in the embryo before
it can synthesize this hormone. This explains why this pool of
osteocalcin determines the quality of spatial learning and mem-
ory in adult offspring. These results indicate that the skeleton via
osteocalcin regulates cognition and is amediator of thematernal
influence on brain development and functions of the offspring
(Broad and Keverne, 2011; Jansson and Powell, 2007).
RESULTS
Osteocalcin Influences the Synthesis of Several
Neurotransmitters
The passivity of the Ocn/mice, a feature reported by all inves-
tigators handling them since they were generated, was quanti-
fied by comparing their locomotion to that of wild-type (WT)
littermates during light and dark phases or over 30 min of an
open-field paradigm test (Figures 1A–1C). Both assays showed
a significant decrease in locomotion in 3-month-old Ocn/
mice. Given that this analysis was conducted in female mice,
this decrease in locomotion could not be ascribed to a lack of
sex steroid hormones as their synthesis is not regulated by
osteocalcin in female mice (Oury et al., 2011) nor was it second-
ary to a measurable deficit in muscle functions (Figure S1A avail-
able online). Locomotion was normal in mice lackingGprc6a, the
only known receptor for osteocalcin (Figures 1A–1C), implying
that the passivity of Ocn/ mice may not be a consequence
of their metabolic abnormalities since these are equally severe
in Ocn/ and Gprc6a/ mice (Figures S1B–S1E). This was
further addressed by including Gprc6a/ mice in subsequent
experiments.
To determine whether this passivity was caused by perturba-
tions in neurotransmitters that have accumulated in the brain,
we measured neurotransmitter content in various areas of the
brain of 3-month-old WT, Ocn/, and Gprc6a/ mice. This
analysis showed that GABA content was increased in all brain
areas tested in Ocn/ compared to WT mice (Figure 1D). In
contrast, norepinephrine and serotonin contents were signifi-
cantly decreased in the brainstem, whereas that of dopaminewas decreased in the midbrain, cortex, and striatum of Ocn/
mice (Figures 1E–1G). Glutamate levels were normal in the
brains ofOcn/mice (Figure S1I). The contents of all these neu-
rotransmitters were similar in WT and Gprc6a/ brains (Figures
S1F–S1H).
An explanation for the changes in neurotransmitter accumula-
tion in Ocn/ mice is the alteration in expression of genes
necessary for neurotransmitter biosynthesis. Expression of
Gad1 and Gad2, two enzymes required for GABA biosynthesis,
was increased in the brainstems of Ocn/ mice (Figure 1H).
Expression of Tph2, the gene encoding the initial enzyme
needed for brain serotonin synthesis (Walther et al., 2003), and
of Th that encodes the initial enzyme in dopamine and norepi-
nephrine synthesis (Daubner et al., 2011; Palmiter, 2008) was
decreased in the brainstem and midbrain, respectively (Fig-
ure 1H). Conversely, in Esp/ mice, which display an increase
in the circulating levels of the undercarboxylated form of osteo-
calcin (Lee et al., 2007), Tph2 expression in the brainstem was
increased (Figure S1J). All these genes were normally expressed
in Gprc6a/ mice (Figure 1H), further suggesting that osteocal-
cin affects the synthesis of neurotransmitters in a Gprc6a-inde-
pendent manner.
Osteocalcin Favors Several Behaviors
The increase in the content of GABA and the decrease of mono-
amine neurotransmitters (serotonin and catecholamine) in the
brains of Ocn/ mice should hamper their behavior. This was
assessed in female WT, Ocn/, and Gprc6a/ mice.
Anxiety-like behavior was analyzed by three conflict-based
tests. The dark/light transition test exploits the innate aversion
of rodents to brightly illuminated areas (Crawley, 1985; David
et al., 2009). The test apparatus consists of a dark, safe compart-
ment and an illuminated, aversive one. Three parameters were
recorded: (1) latency to enter the lit compartment, (2) time spent
in the lit compartment, and (3) the number of transitions between
compartments.Ocn/mice displayed longer latency and spent
less time in the lit compartment, two indexes of anxiety-related
behavior (Figure 2A). They also made fewer transitions between
compartments, an index of anxiety-like behavior and of motor-
exploratory activity (Figure 2A). The next test, the elevated plus
maze test (EPMT) (Holmes et al., 2000; Lira et al., 2003), relies
on the aversion of rodents to open spaces. The EPMT is
comprised of two open and two enclosed arms. Testing takes
place in bright ambient light conditions. Animals are placed
onto the central area facing one closed arm and allowed to
explore for 5 min. Anxiety-related behavior is defined in this
test by a lesser proportion of time spent and fewer entries in
the open arms. This is what was observed in Ocn/ mice (Fig-
ure 2B). In the third test, the open-field test (OFT) (David et al.,
2009), mice are placed in the center of the open-field box and
video-tracked under normal light conditions for 30 min. Ocn/
mice showed a drastic decrease in the distance moved, time
spent in the center, and vertical activity compared to WT litter-
mates, all features indicative of greater anxiety-like behavior
and decreased exploratory activity (Figure 2C).
Anxiety is often accompanied by depression. This was first
assessed by the tail suspension test (TST) in which animals
are subjected to the inescapable stress of being suspended byCell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc. 229
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Figure 1. Osteocalcin Affects the Biosyn-
thesis of Neurotransmitters
(A and B) Measurements of (A) total (XTOT) and
(B) ambulatory activity (AMBX) in Ocn/ and
Gprc6a/mice during 12 hr light and dark phases
over 3 days. Mutant mice were compared to their
WT littermates.
(C) Video tracking of an OFT performed in Ocn/,
Gprc6a/, and WT littermate mice.
(D–G) GABA (D), serotonin (E), dopamine (F), and
norepinephrine (G) contents in various parts of the
brains of Ocn/ and WT mice.
(H) Expression (qPCR) of Tryptophan hydroxylase-
2 (Tph2),Glutamate decarboxylase-1 and -2 (Gad1
and Gad2), and Tyrosine hydroxylase (Th) in the
brainstems and midbrains of Ocn/, Gprc6a/,
and control mice.
Error bars represent SEM. The statistical test on
the top of each graph represents the Student’s
t test; p < 0.05 is significant.their tails (Cryan et al., 2005; David et al., 2009). In this test,
an index of helplessness is the time spent immobile. This
time was significantly increased in Ocn/ mice (Figure 2D). In
the forced swim test (FST), mice are forced to swim over
6 min in a glass cylinder filled with water from which they
cannot escape. Over time, mice cease their attempts to escape
and float passively, an indication of a depression-like behavior.230 Cell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc.Ocn/ mice spent 45% more time
floating than WT mice (Figure 2E).
Spatial learning and memory were
assayed through the Morris water maze
test (MWMT) that is thought to reflect
functions of the hippocampus. This test
relies on the ability of mice to use
spatial cues to locate a submerged plat-
form. Spatial learning is assessed
through four trials a day for 10 to
12 days. Ocn/ mice showed a nearly
complete inability to learn over the course
of 10 days (Figure 2F). Taken together,
these tests showed that osteocalcin
exerts a significant influence on anxiety,
depression-like behaviors, learning, and
memory. An electroretinogram did not
detect any difference between Ocn/
and WT mice, thus ruling out that these
behavioral abnormalities were secondary
to blindness (Figure S2A). Gprc6a/
mice were indistinguishable from WT
littermates for all these tests (Figures
2A–2E and 2G).
Osteocalcin Signals in Discrete
Areas of the Brain
Next we asked through a variety of
approaches whether the molecular and
behavioral abnormalities observed inOcn/mice were indicative of a direct signaling of this hormone
in the brain.
We first tested whether osteocalcin crossed the BBB. For
that purpose, we delivered subcutaneously vehicle or recombi-
nant uncarboxylated, full-length, mouse osteocalcin (hereafter
referred to as osteocalcin) in 3-month-old Ocn/ mice. As a
positive control, leptin, which crosses the BBB (Banks et al.,
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Figure 2. Osteocalcin Affects Several Behaviors
(A) DLT: The latency (Sec) to enter the lit compartment, number of transitions between compartments and time spent in the lit compartment were measured.
(B) EPMT: Number of entries and time spent (Sec) in the open arms were scored.
(C) OFT: Total distance (cm), % of the distance traveled in the center versus periphery, % of the time spent in the center versus periphery, and number of rearing
events were measured. The video tracking of each group of mice is represented on the right panel.
(D and E) Representation of the time spent (Sec) immobile during the (D) TST and (E) the FST. Both tests assess depression-like behavior.
(F andG)MWMTperformed over 12 days. The graphic shows the time (seconds) needed for each group of mice to localize a submerged platform in the swimming
area. The video tracking on the left panel represents the standards obtained for each group analyzed.
Error bars represent SEM. The statistical test on the top of each graph represents the Student’s t test, (a) means p value of < 0.05 versusWT; p < 0.05 is significant.1996), was delivered in the same conditions in 3-month-old
ob/ob mice. Seven days later, leptin and osteocalcin contents
were measured in the blood and various parts of the brain of
ob/ob and Ocn/ mice, respectively. As expected, leptin was
detected in the brainstem and hypothalamus of ob/ob mice
(Yadav et al., 2009) (Figure S3A), as for osteocalcin it accumu-
lated in the brainstem, thalamus, and hypothalamus of Ocn/
mice (Figure 3A). In the conditions of this assay, the quantity of
osteocalcin that accumulated in each location in the brains of
Ocn/ mice was similar to that observed in the brains of WT
mice (Figures 3A and S3B). When using carboxylated, full-lengthmouse osteocalcin (hereafter referred to as carboxylated osteo-
calcin), significantly less accumulated in the brainstem and
hypothalamus and none in the midbrain (Figure 3A).
To determine whether osteocalcin binds to neurons, we incu-
bated sections of adult mouse brains with biotinylated uncar-
boxylated osteocalcin (300 ng/ml) or GST-biotin alone (1.5 mg/
ml) followed by immunofluorescence analysis with an anti-biotin
antibody. In the midbrain, osteocalcin bound to neurons in the
ventral tegmental area, a nucleus located close to the midline
on the floor of the midbrain and enriched in dopaminergic
neurons; in the brainstem, binding was detected in the dorsalCell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc. 231
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Figure 3. Osteocalcin Binds to Neurons in the Brain
(A) Measurement of osteocalcin in bone, serum, cortex, midbrain, hypothalamus, and brainstem of Ocn/ mice receiving either PBS (first column),
uncarboxylated (second column), or carboxylated (third column) osteocalcin s.c. during 7 days.
(B) Binding of GST-biotin (1.5 mg/ml) (panel 1) and biotinylated uncarboxylated osteocalcin (300 ng/ml) (panels 2–4) to the dorsal (DR) (first row) and median (MR)
(second row) raphe nuclei of the brainstem (identified by anti-5-HT immunofluorescence), to the ventral tegmental area (VTA) (third row) of the midbrain (identified
by anti-TH immunofluorescence), and to the CA3 region (fourth row) of the hippocampus (identified anatomically). Panel 5: competition with unlabeled osteo-
calcin (1000-fold excess). Scale bars = 100 mm.
(C) Expression of Tph2 and Gad1 in brainstem and of Th in midbrain explants from WT and Gprc6a/ mice, treated with 3 ng/ml osteocalcin or vehicle.
(D) Gene expression in mouse primary hindbrain neurons treated with osteocalcin (10 ng/ml) or vehicle.
(E) Calcium flux of hindbrain neurons responsive (n = 7) and unresponsive (n = 5) to osteocalcin (30 ng/ml).
(F and G) Extracellular current recordings of (F) neurons of the dorsal raphe nucleus and (G) GABAergic interneurons of the brainstem treated with osteocalcin
(10 ng/ml).
Error bars represent SEM. The statistical test on the top of each graph represents the Student’s t test; p < 0.05 is significant.and median raphe nuclei that contain serotonergic neurons, and
in the hippocampus, osteocalcin bound to neurons of the CA3
region of the hippocampus (Figure 3B). In each location, this
binding was specific as it was displaced by unlabeled osteocal-
cin (Figure 3B).
Second we asked whether, ex vivo, osteocalcin could signal in
neurons to influence expression of genes needed for neurotrans-
mitter synthesis. Brains were sliced at the level of themedian and232 Cell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc.dorsal raphe of the brainstem so that they would be enriched in
serotonin-producing neurons, or at the level of the substantia
nigrae and ventral tegmental areas (VTAs) of the midbrain.
Osteocalcin decreased Gad1 expression and increased Tph2
and Th expression in brainstem and midbrain explants, respec-
tively, regardless of their genotypes (Figure 3C). Osteocalcin
also decreased Gad1 expression by 65% and increased Tph2
expression 3-fold when added to primary hindbrain neuron
0.03
0.94
0.03
Ti
m
e 
sp
en
t i
n 
Op
en
 A
rm
s
 (S
ec
)
20
0  
10
30
40
50
60
70
80
Nu
m
be
r o
f e
nt
rie
s 
in
 o
pe
n 
Ar
m
s 
4
0  
2
6
8
10
12
14
100
B
La
te
nc
y 
to
 e
nt
er
 in
 th
e 
lit
co
m
pa
rtm
en
t  
(S
ec
)
20
0  
10
30
40
50
60
Nu
m
be
r o
f e
nt
rie
s 
in
 th
e
 li
t c
om
pa
rtm
en
t
4
0  
2
6
8
10
12
Ti
m
e 
sp
en
t i
n 
th
e 
lit
co
m
pa
rtm
en
t  
(S
ec
)
20
0  
10
30
40
50
60
70
80
70
A
C WT - PBS - PUMP                                 (n=7)
Ocn-/- - Osteocalcin - PUMP              (n=7)
Ocn-/- - PBS - PUMP (n=7)
To
ta
l D
is
ta
nc
e 
(c
m
)
1000
500
1500
2000
2500
3000
3500
4000
%
 D
is
ta
nc
e 
Ce
nt
er
 v
s
 D
is
ta
nc
e 
Pe
rip
he
ry
 
4.0
2.0
6.0
8.0
10.0
12.0
%
 T
im
e 
Ce
nt
er
 v
s
 T
im
e 
Pe
rip
he
ry
 
W
T  +
 P
B
S
-P
U
M
P
O
cn
-/-
 +
 P
B
S
-P
U
M
P
O
cn
-/-
 
+ 
os
te
oc
al
ci
n-
P
U
M
P
Ti
m
e 
sp
en
t i
m
m
ob
ile
 (S
ec
)
40
0  
20
60
80
100
120
140
160
D
Ti
m
e 
sp
en
t i
m
m
ob
ile
 (S
ec
)
40
0  
20
60
80
100
120
140
160
0.05
0.1
0.002
E
Re
la
tiv
e 
ex
pr
es
si
on
 o
f
 O
st
eo
ca
lc
in
 to
 W
T 
Bo
ne
 (%
)
0  
25
50
75
100
Ocn-/- (n=9)
WT      (n=9)
120
Co
rte
x
St
ria
tumBo
ne
Hi
pp
o
Hy
po
tha
lam
us
Ce
reb
ell
um
G
0.08
0.45
0.05
0.001
0.42
0.004
0.01
0.31
0.008
4.0
2.0
6.0
8.0
10.0
12.0
0.02
0.8
0.2 0.05
0.6
0.1
0.006
0.4
0.01
0.04
0.8
0.03
0.06
0.9
0.1 0.04
0.8
0.03
0.50
0  
0.25
0.75
1.00
1.25
1.50
0.06
0.9
0.05
WT - PBS - PUMP                    (n=6)
Ocn-/- - Osteocalcin - PUMP (n=7)
Ocn-/- - PBS - PUMP (n=6)
G
en
e 
ex
pr
es
si
on
 re
la
tiv
e 
to
 W
T
F
Gad1 Gad2
Brainstem
WT - PBS - PUMP                                 (n=7)
Ocn-/- - Osteocalcin - PUMP              (n=7)
Ocn-/- - PBS - PUMP (n=7)
WT - PBS - PUMP                                 (n=7)
Ocn-/- - Osteocalcin - PUMP              (n=7)
Ocn-/- - PBS - PUMP (n=7)
WT - PBS - PUMP                                 (n=7)
Ocn-/- - Osteocalcin - PUMP              (n=7)
Ocn-/- - PBS - PUMP (n=7)
WT - PBS - PUMP                                 (n=7)
Ocn-/- - Osteocalcin - PUMP              (n=7)
Ocn-/- - PBS - PUMP (n=7)
H
Ocn
Ocn
Ocn-/-
WT
Bone
Ocn
Mi
db
ra
in
Br
ain
ste
m
Tph2 Th
Midbrain
0.004
0.85
0.48
0.03
0.64
0.01
90
100
0  0  0  
1.75
WT
Brain
Figure 4. Osteocalcin Signaling in the Brain Prevents Anxiety and Depression
(A–E) DLT (A), EPMT (B), OFT (C), FST (D), and TST (E) performed in WT (n = 7) and Ocn/ mice infused with vehicle (n = 7) or osteocalcin (10 ng/hr) (n = 7).
(F) Expression (qPCR) of Tph2, Gad1, and Gad2 in brainstem and Th in midbrain of WT (n = 6) and Ocn/ mice infused with vehicle (n = 6) or uncarboxylated
mouse osteocalcin (10 ng/hr) (n = 7).
(G) Gene-expression analysis (qPCR) in bone and in the cortex, striatum, hippocampus, hypothalamus, midbrain, brainstem, and cerebellum in WT and
Ocn/ mice.
(H) In situ hybridization of Ocn in WT and Ocn/ adult brain (sagittal sections are represented) (scale bars = 1 mm) and in WT bone as a control (scale
bars = 0.5 mm).
Error bars represent SEM. The statistical test on the top of each graph represents the Student’s t test; p < 0.05 is significant.cultures (Figure 3D). Osteocalcin influenced gene expression in a
dose-dependent manner but with different optimal concentra-
tions for each gene (Figure S3C). Two more assays confirmed
that osteocalcin could signal in neurons of the brainstem. First,
osteocalcin (30 ng/ml) induced calcium flux in hindbrain neurons
collected at embryonic day 14.5 (E14.5) (Figure 3E); second,
whole-cell current clamp recording showed that osteocalcin
could activate the action-potential frequency of neurons in
the brainstem and the locus coeruleus (Figures 3F and S3D).
Osteocalcin also inhibited the action-potential frequency of
the GABAergic interneurons of the brainstem, recognized by
enhanced green fluorescent protein (eGFP) labeling using the
glutamate decarboxylase (GAD)67-GFP knockin mouse model
(Tanaka et al., 2006) (Figure 3G).Lastly we asked whether osteocalcin acts in the brain in vivo
to affect gene expression and behaviors. For that purpose,
we delivered the hormone via intracerebroventricular (ICV)
infusions (10 ng/hr) to Ocn/ mice (Figure S4A). Measure-
ments of osteocalcin in the blood of infused Ocn/ mice
showed that there was no leakage of the centrally delivered
molecule into the general circulation (Figure S4B). This week-
long treatment normalized Tph2, Th, Gad1, and Gad2 expres-
sion and corrected fully anxiety and depression and partially
the spatial learning and memory defects in Ocn/ mice (Fig-
ures 4A–4F and S4C). Collectively, results of these ex and
in vivo assays indicate that osteocalcin regulates neurotrans-
mitter synthesis and behaviors in the mouse by directly acting
in the brain.Cell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc. 233
In view of the results presented above, to verify that there was
no cryptic expression of Ocn in the brain, we used quantitative
PCR (qPCR), in situ hybridization, andmCherry detection in adult
mice in which the mCherry reporter gene had been knocked in
the Ocn locus (Oury et al., 2011). None of these assays revealed
an expression of Ocn in any part of the WT mouse brain above
what was seen in Ocn/ brains, and there was no detectable
signal in Ocn-mcherry brains (Figures 4G–4H, S4D, and S4E).
Osteocalcin Signals in the Brain Postnatally
In the next experiment, we askedwhether osteocalcin influences
behaviors and neurotransmitter synthesis by acting postnatally.
To that end, we crossed mice harboring a floxed allele of Ocn
with mice expressing CreERT2 under the control of the osteo-
blast-specific regulatory elements of the mouse a1Col1 gene
(Ocnosb
ERT2) (Kim et al., 2004).Ocnosb
ERT2mice showed a signif-
icant reduction (52%) of osteocalcin circulating levels following
treatment with tamoxifen, thus verifying that we had efficiently,
even if partially, inactivated this gene (Figure S5).
Six week-old a1Col1-CreERT2, Ocnflox/flox, and Ocnosb
ERT2
mice were injected daily with tamoxifen (1 mg/20 g of body
weight) for 1 week and every 3 weeks to ensure that a stable
deletion of Ocn was achieved and analyzed at 12 weeks of
age. Tamoxifen-treated Ocnosb
ERT2 mice showed a significant
decrease in locomotion and an increase in anxiety- and depres-
sion-like behaviors compared to a1Col1-CreERT2 or Ocnflox/flox
mice (Figures 5A–5E).Gad1 andGad2 expression was increased
in tamoxifen-treated Ocnosb
ERT2 mice; this defect was partially
corrected upon osteocalcin ICV infusion (Figure 5F). There was
also a decrease in the content of serotonin and norepinephrine
in the brainstem and of dopamine in the striatum of Ocnosb
ERT2
mice (Figure 5G). Hence, osteocalcin acts postnatally to affect
neurotransmitter synthesis and behaviors.
Maternal Osteocalcin Is Needed for Proper Fetal Brain
Development
Most importantly, Ocnosb
ERT2 mice differed from Ocn/ mice in
two critical respects. First, spatial learning and memory were
less severely affected in tamoxifen-treated Ocnosb
ERT2 than in
Ocn/ or even Ocn+/ mice (Figure 5H). Second, the near
absence of the corpus callosum and the marked decrease in
the area of the dentate gyrus noted in all Ocn/ mice analyzed
were never seen in tamoxifen-treated Ocnosb
ERT2 mice (Fig-
ure 5I). These observations suggested that osteocalcin influ-
ences fetal brain development.
Analysis of Ocn expression during development between
E13.5 and E18.5 showed that this gene starts to be expressed
in the developing skeleton at E16.5 and is not expressed any-
where in the brain at any of these developmental stages (Figures
6A, S6A, and S6B). The same was true when analyzing Ocn-
mCherry embryos (Figure S6C). And yet, osteocalcin was readily
measured in the blood of E14.5 embryos, i.e., 2 days before
expression of the gene becomes detectable (Figure 6B).
Because Ocn is not expressed in the placenta (Figure 6A), the
only explanation for this observation is that maternal osteocalcin
reaches the fetal blood stream. An ex vivo dual-perfusion system
that monitors the transport of substances across the mouse
placenta (Goeden and Bonnin, 2013) showed that osteocalcin234 Cell 155, 228–241, September 26, 2013 ª2013 Elsevier Inc.could cross the placenta starting at E14.5 (Figure 6C). A larger
transfer of maternal osteocalcin to the fetal circulation was
observed at E15.5 and E18.5 (Figure 6C). In this assay, carbox-
ylated osteocalcin failed to cross the placenta of pregnant mice
at day 18.5 of gestation (Figure S6D).
In view of these results, we next used an ELISA to measure
serum levels of the various forms of osteocalcin in embryos of
various genotypes and origins (Ferron et al., 2010) (Figures
S6E and S6F). That osteocalcin was detectable in the serum of
E18.5 Ocn/ embryos carried by Ocn+/ mothers established
formally that maternal osteocalcin crosses the placenta in vivo
(Figures 6D and S6E). Still at E18.5, osteocalcin circulating levels
were 45% lower inWT embryos when their mothers were Ocn+/
than when their mothers were WT (Figures 6D and S6E). Like-
wise, osteocalcin circulating levels in E18.5 Ocn+/ embryos
were 45% decreased when mothers were Ocn/ compared to
WT mothers (Figures 6D and S6E). In E16.5 embryos, osteocal-
cin circulating levels in WT embryos carried byWTmothers were
7.2 ng/ml but undetectable in embryos of any genotype carried
by Ocn+/ mothers (Figure 6D). These results indicate that
maternally derived osteocalcin contributes to the majority of
the pool of this hormone present in the serum of embryos at
E16.5 and E18.5.
To determine the nature and extent of the influence ofmaternal
osteocalcin on fetal brain development, we relied on histology
and cell biology approaches. Regardless of the genotype of
the mothers, there was no difference in the ratio of brain weight
over body weight between WT and Ocn/ embryos at E16.5
(Figure S6G). By contrast, when compared to WT embryos car-
ried by WT mothers, this ratio was markedly decreased in E18.5
Ocn/ embryos if mothers were Ocn/ mothers but not if they
were Ocn+/ (Figure S6H). Cresyl violet staining of histological
sections showed an enlargement of the cerebral ventricles in
the brains of E18.5 Ocn/ embryos originating from Ocn/
mothers compared to what was seen in WT embryos originating
from WT mothers. This enlargement was not seen in either of
these embryos when they originated from Ocn+/ mothers (Fig-
ure 6E). The absence of osteocalcin in embryos also caused
neuronal apoptosis of different severity depending on the geno-
types of the mothers. Specifically, there was a 2-fold increase in
the number of apoptotic cells in the hippocampus of E18.5
Ocn/ embryos compared to WT embryos originating from
WT mothers only if their mothers were Ocn/ (Figures 6F and
S6I). Neuronal apoptosis was not seen throughout the brain
and for instance was absent in the septal nuclei of Ocn/
mice (Figure S6J). These results indicate that maternal osteocal-
cin affects fetal neurogenesis.
Maternal Osteocalcin Influences Spatial Learning and
Memory and Neurogenesis in Adult Offspring
The influence of maternal osteocalcin on fetal neurogenesis led
us to test whether this pool of the hormone also affects cognition
and neurogenesis in the adult offspring.
Given the massive apoptosis observed in the hippocampal re-
gion, we first asked, through the use of a three-shock contextual
fear-conditioning paradigm (CFC), if the learning deficit revealed
inOcn/mice in the MWMT could be better linked to the hippo-
campus and if its severity was influenced by the genotype of the
Figure 5. Osteocalcin Regulates Brain Functions Postnatally
(A–E and H) DLT (A), EPMT (B), FST (C), OFT (D), TST (E), and MWMT (H) performed in a cohort of Ocnflox/flox, a1Col1-CreERT2, and Ocnosb
ERT2 mice.
(F) Expression (qPCR) of Gad1 and Gad2 in brainstem and striatum of Ocnflox/flox, a1Col1-CreERT2, and Ocnosb
ERT2 mice.
(G)HPLCanalysis of serotonin, dopamine, and norepinephrine contents in brainstem,midbrain, and striatumofOcnflox/flox,a1Col1-CreERT2, andOcnosb
ERT2mice.
(I) Cresyl violet staining andNeuN immunofluorescence of controlOcn/ andOcnosb
ERT2 hippocampi. The dentate gyrus area (% versusWT) is represented in the
right panel.
In each panel (A–F and H), ‘‘Total Control’’ means a1Col1-CreERT2 andOcnflox/floxmice combined. Scale bars = 0.5mm. Error bars represent SEM. The statistical
test on the top of each graph represents the Student’s t test; p < 0.05 is significant.
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Figure 6. Maternal Osteocalcin Favors Fetal Neurogenesis
(A) Expression of Ocn (qPCR) in bone, brain, and placenta of WT and Ocn/ newborns (postnatal day [P] 0) and embryos (E13.5–E18.5).
(B) Osteocalcin circulating levels in WT or Ocn/ newborns (P0) and embryos (E13.5–E18.5).
(C) Ex vivo dual-perfusion system that monitors the transport of osteocalcin across the placenta. Uncarboxylated mouse osteocalcin (300 ng/ml) was injected
through the uterine artery in placentas obtained from WT mice at E14.5, E15.5, and E18.5 of pregnancy. Osteocalcin in fetal eluates is represented as % of
maternal input.
(D) Circulating levels of osteocalcin inWT embryos originating fromWT orOcn+/mothers, ofOcn+/ embryos originating fromOcn+/ orOcn/mothers, and of
Ocn/ embryos originating from Ocn+/ or Ocn/ mothers. Measurements were performed at E16.5 and E18.5.
(legend continued on next page)
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mothers. Ocn/ mice born from Ocn/ mothers exhibited
significantly less context-elicited freezing than WT or Ocn/
mice born from Ocn+/ mothers in the context A and a similar
context A0 (Figure 6G). Next, we used a modified version of the
novel object recognition (NOR) paradigm (Ennaceur and Dela-
cour, 1988; Denny et al., 2012) that assesses the rodent’s ability
to recognize a novel object in the environment. General activity
(grid crossings) and object investigation (averaged across the
two objects) were measured during two exposures. In the first
one, mice were exposed to two objects, while in a second expo-
sure, they faced a constant and a novel object and the parameter
measured was the time spent for exploration of the novel object.
A longer exploratory period betrays a hippocampal deficit in 129
sv/ev mice (Denny et al., 2012). This is what was observed in
Ocn/ mice born from Ocn/ mothers compared to Ocn/
mice born from Ocn+/ mothers or WT mice (Figure 6H). Hence,
both tests suggest a hippocampal origin to the spatial learning
and memory defects seen in Ocn/ mice.
To determine whether this deficit in spatial learning and mem-
ory was associated with an impairment of adult neurogenesis in
the hippocampus, we performed BrdU staining and doublecortin
(DCX) immunohistochemistry in the hippocampal regions of
3-month-old mice. There was a significant reduction in the
number of DCX+ and BrdU+ neurons in Ocn/ mice compared
to WT mice regardless of the genotype of the mothers, although
this reduction was more severe if mothers were Ocn/ (Figures
6I and 6J). Hence, the maternal pool of osteocalcin is necessary
for hippocampus-dependent learning in adult mice in part
because it affects adult hippocampal neurogenesis.
The functions of the maternal pool of osteocalcin described
above implied that delivering the hormone to Ocn/ females
during their pregnancy could normalize hippocampal neurogen-
esis in Ocn/ embryos and might improve behaviors in adult
Ocn/ offspring. This was tested following once-a-day injec-
tions of osteocalcin (240 ng/day) to pregnant Ocn/ females
mated with Ocn/ males from E0.5 to E18.5. Neither mothers
nor pups received the hormone after birth.
This treatment had mild effect on parameters of anxiety or
depression (except in the OFT) in 3-month-old Ocn/ offspring
but rescued almost entirely their deficit in learning and memory
(Figures 7A–7F). To explain this striking rescue of spatial learning
and memory, we conducted histological and biochemical ana-
lyses. The enlargement of the cerebral ventricles and the
increase in neuronal apoptosis seen in the brains of E18.5
Ocn/ embryos carried byOcn/mothers were absent if these(E) Cresyl violet stain of lateral ventricles of hippocampi of E18.5 WT embryos o
Ocn/ mothers. The measurements of the lateral ventricle area over brain area
(F) Number of apoptotic cells (stained by TUNNEL assay) in hippocampi of E18.5
Ocn/ mothers.
(G and H) CFC (G) and NOR (H) performed in WT andOcn/mice born fromOcn
Ocn/ mothers mice exhibited significantly less context-elicited freezing than W
exploratory period in Ocn/ mice born from Ocn/ mothers compared to Oc
introduced.
(I and J) BrdU and DCX Immunohistochemistry showing a significantly lower num
mice born from Ocn/ or Ocn+/ mothers. This decrease was even more prono
For (A)–(F), (I) and (J), the statistical test on the top of each graph represents the
the top of each graph represents an ANOVA. Significant ANOVAs were followed u
***p value < 0.001.mothers had been injected with osteocalcin throughout their
pregnancies (Figures 7G and 7H), and a Western blot analysis
showed a decrease in caspase 3 cleaved levels in hippocampi
of Ocn/ embryos carried by osteocalcin-injected Ocn/
mothers (Figure S7). In 3-month-old offspring, cresyl violet stain-
ing and NeuN immunofluorescence showed a normalization of
the area of the dentate gyrus in the hippocampi of Ocn/
mice originating from osteocalcin-injected Ocn/ mothers (Fig-
ure 7I). Likewise, the contents of serotonin and norepinephrine
were similar in 3-month-old WT and Ocn/ mice born from
osteocalcin-injected Ocn/ mothers (Figure 7J); the content of
dopamine that was low in the striatum ofOcn/mice (Figure 1F)
was also normalized in Ocn/ mice born from osteocalcin-
injected Ocn/ mothers (Figure 7J). GABA levels remained
elevated in the offspring of osteocalcin-injected Ocn/ mice,
albeit not significantly (Figure 7K). These experiments indicate
that the maternal pool of osteocalcin is necessary for the acqui-
sition of learning- and memory-like behaviors in the adult
offspring in part because it prevents neuronal apoptosis in the
hippocampus.
DISCUSSION
This study shows that the bone-derived hormone osteocalcin
affects brain development and functions. After birth, osteocalcin
favors neurotransmitter synthesis and postnatal neurogenesis,
prevents anxiety- and depression-like behaviors, and enhances
spatial learning and memory. During embryonic development,
maternal osteocalcin crosses the placenta and prevents
neuronal apoptosis in the hippocampus. This pool of the hor-
mone is also required for optimal spatial learning and memory
in the adult offspring. These results broaden the spectrum of
functions of the skeleton, provide a molecular basis for the
long-observed maternal influence on fetal brain development,
and shed light on the cause of the decrease of cognitive func-
tions with aging.
Signaling of Bone in the Brain
That a high serotonin content in the brain results in a high bone
mass despite a hypogonadism (Ducy et al., 2000; Yadav et al.,
2009) illustrates how powerful the central control of bone mass
is and was an incentive to ask whether bone, in a feedback
loop, affects development and/or functions of the brain. To
address this question, we focused on osteocalcin because of
the obvious passivity of the Ocn/ mice that was not due toriginating from WT mothers and Ocn/ embryos originating from Ocn+/ or
are represented below the images (in %) (scale bars = 0.5 mm).
WT embryos carried by WT mothers and Ocn/ embryos carried by Ocn+/ or
/ orOcn+/mothers (n = 7–18 per group). In the CFC,Ocn/mice born from
T mice in context A and A0. In the NOR, there was a significant increase in the
n/ mice born from Ocn+/ mothers or WT mice when a novel object was
ber of BrdU+ (I) and DCX+ (J) cells in the dentate gyrus (DG) of WT and Ocn/
unced in the ventral region of the DG. (Scale bars = 0.2 mm.)
Student’s t test; p < 0.05 is significant. For (G) and (H), the statistical test on
p with Fisher’s PLSD tests where appropriate. *p value < 0.05, **p value < 0.01,
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Figure 7. Maternal Osteocalcin Determines Spatial Learning and Memory in Adult Offspring
(A–F) DLT (A), EPMT (B), OFT (C), FST (D), TST (E), and MWMT (F) performed in 3-month-old Ocn/ mice born from Ocn/ mothers injected once a day with
vehicle or osteocalcin (240 ng/day) during pregnancy compared to WT mice.
(G) Surface of the lateral ventricle over brain area (%) of E18.5 hippocampi coronal sections of WT embryos originating from WT mothers and Ocn/ embryos
originating from osteocalcin-injected Ocn/ mothers.
(H) Number of apoptotic cells (stained by TUNNEL assay) of E18.5 hippocampi coronal sections of WT embryos originating from WT mothers and Ocn/
embryos originating from Ocn/ mothers injected with osteocalcin (240 ng/day).
(I) Cresyl violet, NeuN immunofluorescence, and dentate gyrus area (% versus WT) of WT and Ocn/ embryos originating from osteocalcin-injected Ocn/
mothers. Scale bars = 0.5 mm.
(legend continued on next page)
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any obvious muscular or metabolic causes. This investigation
showed that osteocalcin favors expression of genes necessary
for the synthesis of monoamine neurotransmitters and inhibits
the ones needed for GABA synthesis. As a result, the contents
of serotonin, dopamine, and norepinephrine are low, whereas
that of GABA is high in the brains of Ocn/ mice. Of note, the
decrease in norepinephrine content observed in the brains of
Ocn/ mice may explain the high bone phenotype originally
noted in the Ocn/ mice (Ducy et al., 1996).
Several observations indicate that osteocalcin signals in the
brain. The first one is that this hormone, when uncarboxylated,
crosses the BBB and binds specifically to neurons of the
brainstem, midbrain, and hippocampus. The second one is
that osteocalcin favors the expression of genes necessary
for serotonin and catecholamine synthesis and inhibits the
expression of genes involved in GABA biosynthesis by acting
directly on neurons. Likewise, treatment of hindbrain neurons
with osteocalcin affects calcium flux and the action-poten-
tial-firing rate of various neurons and interneurons of the
brainstem.
Postnatal Functions of Osteocalcin in the Brain
A major consequence of the osteocalcin regulation of neuro-
transmitter synthesis is that this hormone influences behaviors.
For instance, osteocalcin prevents anxiety and depression.
The complete rescue of the anxiety and depression phenotypes
seen inOcn/mice upon ICV infusions of the hormone together
with the deleterious effect of a postnatal Ocn inactivation on
anxiety and depression were two further pieces of evidence
that osteocalcin acts in the brain and postnatally to affect behav-
iors. Osteocalcin also favors spatial learning and memory as
determined by several tests reflecting functions of the hippo-
campus (Morris et al., 1982). This is consistent with the facts
that the dentate gyrus area is smaller and that neuronal survival
and adult neurogenesis in the hippocampus are decreased in
Ocn/ mice.
We note that skeletal dysplasia characterized by a decrease in
bone formation can be associated with cognitive impairment
(McBrien et al., 2006; Nagamatsu et al., 2012; Soule, 1946).
This is, for instance, the case with CCD, a disease caused by a
loss-of-function mutation in Runx2, which is an osteoblast-
specific transcription factor and amajor regulator ofOcn expres-
sion (Ducy et al., 1997; Lee et al., 1997; Mundlos et al., 1997). It is
thus possible that, as is the case for its other functions (Oury
et al., 2013), the neuromodulatory functions of osteocalcin
described in this study may be conserved in humans.
Bone, Osteocalcin, and Organismal Aging
During aging, there is often a decrease in bone mass and a
mild to severe cognitive impairment that in turn favors falls
and bone fractures (Hsu et al., 2012), Hence, a vicious circle
develops between bone mass and cognition during aging. In(J and K) HPLCmeasurements of serotonin (J) and norepinephrine (NE) (J) content
brainstem, midbrain, and striatum (K) of WT and Ocn/ embryos originating fro
Error bars represent SEM. The statistical test on the top of each graph represents
versus WT and (b) means p value of < 0.05 versus Ocn/ originating from Ocnthat regard, our results may be important in two respects.
First, they raise the prospect that a decrease in bone mass
as seen during aging may be a cause of the decrease in
cognitive functions seen in the older population because of
a decrease in the synthesis and/or activation of osteocalcin.
Therefore, they suggest that improving bone health during ag-
ing may have beneficial effects on cognition. The availability of
multiple mouse models with either decreased bone formation
or increased bone resorption will now allow testing of whether
modulating osteocalcin synthesis by osteoblasts or its activa-
tion by bone resorption will affect behaviors. In broader terms,
the fact that osteocalcin favors functions such glucose ho-
meostasis, male fertility, and cognitive functions that deterio-
rate with age raises the testable hypothesis that bone, through
its endocrine function, may be a determinant of organismal
aging.
Functions of Maternal Osteocalcin
Ocn is one of the latest genes to be expressed during skeleto-
genesis, therefore it was expected that this hormone would not
exert any significant functions during development. Our study
shows, however, that the maternal pool of this hormone is
needed for fetal brain development.
Indeed, osteocalcin is detected in the blood of embryos
2 days before they begin to express Ocn, and measurements
of circulating levels of this hormone in WT or Ocn/ embryos
carried by either WT or Ocn+/ mothers showed that the major-
ity of osteocalcin present in the circulation of embryos origi-
nates from the mother. Histological analysis of the brains of
Ocn/ embryos carried by either Ocn/ or Ocn+/ mothers
showed that maternal osteocalcin is needed to prevent
neuronal apoptosis, at least in the hippocampus. The undercar-
boxylated form of osteocalcin, the form that increases insulin
and testosterone biosynthesis (Ferron et al., 2010; Oury et al.,
2013), is also the only one crossing the placenta efficiently.
This, along with the fact that it is also the form of the hormone
that crosses the BBB more efficiently, suggests that it may be
the active form of osteocalcin in the brain (Lee et al., 2007; Fer-
ron et al., 2010).
By affecting fetal brain development, maternal osteocalcin
also favored behavior in the adult offspring, as providing this
hormone to Ocn/ mothers during their pregnancies rescued
almost completely the spatial learning and memory deficits in
their adult Ocn/ progeny. It also improved, albeit modestly,
some parameters of anxiety in these progenies. In view of these
results, it is tempting to speculate that a mediocre bone health in
the mother, leading to a decrease in osteocalcin synthesis, may
contribute to the high incidence of neuropsychiatric diseases in
the children of women undernourished during pregnancy, as
undernutrition hampers bone remodeling (Seibel, 2002). This
hypothesis that has important biomedical implications can be
tested with various animal models.in the brainstem, dopamine content in the striatum (J), andGABA content in the
m osteocalcin-injected Ocn/ mothers.
the Student’s t test; p < 0.05 is significant. For (F), (a) means p value of < 0.05
/ mothers; p < 0.05 is significant.
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Mediation of Osteocalcin Functions in the Brain
The existence of substantial metabolic abnormalities in Ocn/
mice was a a potential confounding factor for the interpretation
of the results. Although we cannot formally rule out that these
metabolic abnormalitiesmay contribute to the behavioral pheno-
types of theOcn/mice, we note that mice lacking Gprc6a, the
only known receptor for osteocalcin, are indistinguishable from
Ocn/ mice in terms of energy metabolism and do not present
any of the molecular and behavioral defects seen in the absence
of Ocn. The behavioral difference existing between Ocn/ and
Gprc6a/ mice suggests that, like other hormones and neuro-
modulators, osteocalcin uses several receptors to fulfill all its
known functions. Hence, our findings raise the question of the
molecular mechanisms used by this hormone in the brain. Ad-
dressing this question on both molecular and genetic grounds
is now a priority if we want to understand the entire spectrum
of functions of osteocalcin in the brain.
EXPERIMENTAL PROCEDURES
Mice and Treatment
Ocn/, Gprc6a/, and Ocnflox/flox mice have been described (Ducy et al.,
1996; Oury et al., 2011). All experimental measurements and behavioral
studies were conducted with female mice only. All mice were maintained on
a pure 129 sv/ev genetic background except the inducible deletionOcnmodel
(Ocnosb
ERT2) (mixed background: 25% C57/BL6 and 75% 129 sv). For induc-
ible gene deletion, tamoxifen was injected daily intraperitoneally (IP) (1 mg/
20 g of body weight) for 7 days. Controls for the inducible inactivation of
Ocn were a1Col1-Cre, Ocnflox/flox, and WT mice. Each group described is
represented individually in each panel. For osteocalcin delivery to pregnant
mice, IP injections (240 ng/day) were performed once a day from E0.5 to
E18.5. For osteocalcin or leptin delivery inOcn/ or ob/obmice, pumps (Alzet
micro-osmotic pump, Model 1002) delivering osteocalcin (300 ng/hr), leptin
(50 ng/hr), or vehicle were surgically installed subcutaneously in the back of
3-month-old mice. For rescues of behaviors in Ocn/ mice, osteocalcin
(10 ng/hr) or vehicle was delivered ICV. Unless specified otherwise, statistical
analyses were performed using two-tailed Student’s t test. Error bars denote
mean ± standard error of the mean (SEM0. A p value of < 0.05 was considered
statistically significant.
Hormonal Measurement
Osteocalcin and leptin contents in serum (ng/ml) and tissues (ng/mg) were
measuredwith specific ELISAs (mouse osteocalcin EIA kit [BT-470 Biomedical
Technologies Inc. and EZML-82K, Millipore]). Circulating levels of the carbox-
ylated, undercarboxylated, or uncarboxylated forms of osteocalcin were
measured by ELISA (Ferron et al., 2010).
Real-Time RNA Transcript Determination
RNA was isolated from primary neurons or tissue using TRIZOL (Invitrogen).
cDNA synthesis was performed following standard, and qPCR analyses
were done using specific qPCR primers from (http://www.sabiosciences.
com/RT2PCR.php) SABiosciences and expressed relative to Gapdh levels.
High-Performance Liquid Chromatography
Serotonin, catecholamine, andGABA contents weremeasured by high-perfor-
mance liquid chromatography (HPLC) (Bach et al., 2011). Neurotransmitter
contents in 7 to 15 mice of each genotype were measured in cerebral cortex,
striatum, hippocampus, hypothalamus, midbrain, brainstem, and cerebellum.
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